Yamasaki Takahiro, Kohda Daisuke
Glyco-Biochemistry Laboratory, Institute for Glyco-core Research (iGCORE), Gifu University, Gifu, Japan.
Division of Structural Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
J Biol Chem. 2025 Apr 30;301(6):108567. doi: 10.1016/j.jbc.2025.108567.
Elucidating the functions of glycosyltransferases is a necessary step toward understanding their biological roles and producing drug leads, cosmetics, and foods that utilize glycans as functional molecules. We found a previously uncharacterized protein classified as a glycosyltransferase encoded in the Actinobacillus minor NM305 genome and named the gene product A. minor glucoside-glucosyltransferase (AmGGT). To clarify the biochemical properties of the AmGGT protein, we determined its substrate specificity and crystal structure. AmGGT exhibited processive glycosyltransferase activity when UDP-Glc was used as the donor substrate and, unexpectedly, showed different acceptor substrate specificity from that of the homologous Agt proteins of other Actinobacillus species. While the homologous proteins transfer glucose residues to the nonreducing end of oligosaccharide chains linked to peptides, AmGGT cannot use glycopeptides as acceptors and requires the nonreducing end of oligosaccharides. The crystal structure provided clues to identify a sequence motif consisting of two pairs of two amino acid residues that defines the acceptor specificity, oligosaccharide, or glycopeptide. Based on this discovery, the acceptor substrate of AmGGT was changed from an oligosaccharide to a glycopeptide by transplanting the sequence motif from the homologous proteins. Furthermore, the AmGGT protein could utilize eukaryotic high-mannose type N-glycans as acceptors, as a model for branched oligosaccharides. The sequential glycosyltransfer activity and controllable substrate specificity of AmGGT will make it a useful tool in glycosyltransferase engineering to synthesize functional glycans and glycoconjugates.
阐明糖基转移酶的功能是理解其生物学作用以及生产以聚糖为功能分子的药物先导物、化妆品和食品的必要步骤。我们在微小放线杆菌NM305基因组中发现了一种以前未被表征的蛋白质,它被归类为一种糖基转移酶,并将该基因产物命名为微小放线杆菌葡萄糖苷 - 葡萄糖基转移酶(AmGGT)。为了阐明AmGGT蛋白的生化特性,我们确定了其底物特异性和晶体结构。当使用UDP - Glc作为供体底物时,AmGGT表现出连续糖基转移酶活性,并且出乎意料的是,它显示出与其他放线杆菌属同源Agt蛋白不同的受体底物特异性。虽然同源蛋白将葡萄糖残基转移到与肽相连的寡糖链的非还原端,但AmGGT不能使用糖肽作为受体,而是需要寡糖的非还原端。晶体结构为鉴定由两对两个氨基酸残基组成的序列基序提供了线索,该序列基序定义了受体特异性、寡糖或糖肽。基于这一发现,通过从同源蛋白移植序列基序,将AmGGT的受体底物从寡糖改变为糖肽。此外,作为分支寡糖的模型,AmGGT蛋白可以利用真核高甘露糖型N - 聚糖作为受体。AmGGT的连续糖基转移活性和可控的底物特异性将使其成为糖基转移酶工程中合成功能性聚糖和糖缀合物的有用工具。